 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/15/2024 |
$7.10 |
$7.26 |
$7.10 |
$7.26 |
2.10K | | 04/16/2024 |
$7.26 |
$7.26 |
$7.26 |
$7.26 |
300 | | 04/17/2024 |
$7.10 |
$7.10 |
$7.10 |
$7.10 |
2.60K | | 04/18/2024 |
$7.10 |
$7.30 |
$7.10 |
$7.10 |
5.20K | | 04/19/2024 |
$7.32 |
$7.32 |
$7.32 |
$7.32 |
3.00K |
|
|
| Titan Pharmaceuticals is a pharmaceutical company developing therapeutics utilizing its drug delivery platform, ProNeura™, for the treatment of select chronic diseases. Probuphine is a product based on its ProNeura technology approved in the United States, Canada and the European Union, for the maintenance treatment of opioid use disorder (OUD). Co. is conducting non-clinical studies with a nalmefene implant for the potential treatment of OUD under a grant from the National Institutes of Health. Co. is collaborating with the Walter Reed Army Institute of Research and South West Research Institute in the early non-clinical evaluation of the ProNeura platform in malaria prophylaxis. | |
|
Titan Pharmaceuticals (TTNP) has the following price history information. Looking back at TTNP historical stock prices for the last five trading days, on April 15, 2024, TTNP opened at $7.10, traded as high as $7.26 and as low as $7.10, and closed at $7.26. Trading volume was a total of 2.10K shares. On April 16, 2024, TTNP opened at $7.26, traded as high as $7.26 and as low as $7.26, and closed at $7.26. Trading volume was a total of 300 shares. On April 17, 2024, TTNP opened at $7.10, traded as high as $7.10 and as low as $7.10, and closed at $7.10. Trading volume was a total of 2.60K shares. On April 18, 2024, TTNP opened at $7.10, traded as high as $7.30 and as low as $7.10, and closed at $7.10. Trading volume was a total of 5.20K shares. On April 19, 2024, TTNP opened at $7.32, traded as high as $7.32 and as low as $7.32, and closed at $7.32. Trading volume was a total of 3.00K shares.
TTNP Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Titan Pharmaceuticals shares, starting with a $10,000 purchase of TTNP, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
04/19/2024 |
|
| Start price/share: |
$2,232.00 |
|
| End price/share: |
$7.32 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.67% |
|
| Average Annual Total Return: |
-43.56% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$32.80 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/15/2024 | $7.26 | | 04/16/2024 | $7.26 | | 04/17/2024 | $7.10 | | 04/18/2024 | $7.10 | | 04/19/2024 | $7.32 |
|
|
Free TTNP Email Alerts:
